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The aim of this systematic review and meta-analysis was to evaluate the effects of
Nigella sativa (N. sativa) on glycemic control, lipid profiles, and biomarkers of inflam-
matory and oxidative stress. Two independent authors systematically examined
online databases consisting of, EMBASE, Scopus, PubMed, Cochrane Library, and
Web of Science from inception until October 30, 2019. Cochrane Collaboration risk
of bias tool was applied to assess the methodological quality of the studied trials. The
heterogeneity among the included studies were assessed using the Cochrane's Q test
and I-square (I2) statistic. Data were pooled using a random-effects model and
weighted mean difference (WMD) was considered as the overall effect size. A total
of 50 trials were included in this meta-analysis. We found a significant reduction in
total cholesterol (WMD: −16.80; 95% CI: −21.04, −12.55), triglycerides (WMD:
−15.73; 95% CI: −20.77, −10.69), LDL-cholesterol (WMD: −18.45; 95% CI: −22.44,
−14.94) and VLDL-cholesterol (WMD: −3.72; 95% CI: −7.27, −0.18) following sup-
plementation with N. sativa. In addition, there was significant reductive effect
observed with N. sativa on fasting glucose (WMD: −15.18; 95% CI: −19.82, −10.55)
and HbA1C levels (WMD: −0.45; 95% CI: −0.66, −0.23). Effects of N. sativa on CRP
(WMD: −3.61; 95% CI: −9.23, 2.01), TNF-α (WMD: −1.18; 95% CI: −3.23, 0.86),
TAC (WMD: 0.31; 95% CI: 0.00, 0.63), and MDA levels (WMD: −0.95; 95% CI:
−2.18, 0.27) were insignificant. This meta-analysis demonstrated the beneficial
effects of N. sativa on fasting glucose, HbA1c, triglycerides, total-, VLDL-, LDL-
cholesterol levels.
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